Herbalife (HLF) EBITDA (2009 - 2026)

Herbalife has disclosed EBITDA across 18 years of filings, most recently posting $138.4 million for Q1 2026.

• EBITDA for Q1 2026 came in at $138.4 million, up 12.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $496.6 million (up 13.69% YoY), and the FY2025 annual result was $481.0 million, up 24.64% from the prior year.
• EBITDA came in at $138.4 million for Q1 2026 at Herbalife, up from $99.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $155.8 million in Q2 2022 to a low of $55.8 million in Q4 2023.
• The 5-year median for EBITDA is $122.8 million (2025), against an average of $112.2 million.
• Across the five-year window, EBITDA jumped 116.71% in 2022 and plunged 53.95% in 2023, its largest moves.
• Herbalife's EBITDA stood at $88.9 million in 2022, then sank by 37.23% to $55.8 million in 2023, then surged by 90.86% to $106.5 million in 2024, then retreated by 6.29% to $99.8 million in 2025, then soared by 38.68% to $138.4 million in 2026.
• The last three EBITDA figures came in at $138.4 million (Q1 2026), $99.8 million (Q4 2025), and $125.8 million (Q3 2025), per Business Quant data.